Latest filing published 20 Nov 2007 for ReShape Lifesciences Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Aberdare GP II, L.L.C.: trading record in brief
Aberdare GP II, L.L.C. is a declared insider of ReShape Lifesciences Inc., with filings sourced from SEC (Form 4). Between 15 November 2007 and 20 November 2007, the trades on record add up to 7 filings.
On the market, this insider has only ever bought: 3 purchases, €1.4M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €669k and half below.
Most recently, on 20 November 2007, the filings show a transaction in ReShape Lifesciences Inc. The last insider purchase was made public on 19 November 2007, 6,930 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Aberdare GP II, L.L.C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,934 sharesCommon StockSEC:0001181431-07-070726:0
- 1,188,058 sharesCommon StockSEC:0001181431-07-070726:1
- 237,254 sharesCommon StockSEC:0001181431-07-070726:2
- 58,091 sharesCommon StockSEC:0001181431-07-070726:3
- 2,770 shares@ US$8.00Common StockSEC:0001181431-07-070482:0Canonical exit: 13 Feb 2008 (T+90)
- 122,230 shares@ US$8.00Common StockSEC:0001181431-07-070482:1Canonical exit: 13 Feb 2008 (T+90)
- 125,000 shares@ US$8.00Common StockSEC:0001181431-07-070482:2Canonical exit: 13 Feb 2008 (T+90)
7 of 7 declarations